Table 3.
Total influenza-related events and associated costs (in 2014 local currencies) avoided by using QIV instead of TIV in the population of analysis over the study period.
| Brazil (2010–2014) | Colombia* (2007–2014, 2009 excluded) | Panama* (2006–2014, 2009 excluded) | |
|---|---|---|---|
| Outcomes | |||
| Influenza cases avoided | 615,040 | 29,665 | 11,582 |
| GP consultations avoided | 326,494 | 11,204–21,607 | 5,650–8,424 |
| Lost working days avoided | 389,380 | 13,235–26,487 | 7,318–11,416 |
| Hospitalizations avoided | 11,732 | 511–7,775 | 47–2,861 |
| Deaths avoided | 1,385 | 34–1,524 | 8–706 |
| Influenza-associated costs | |||
| GP consultation costs avoided | BRL 3,264,939 | COP 624–1,325 million | PAB 66,827–99,645 |
| Hospitalization costs avoided | BRL 14,715,777 | COP 841–20,307 million | PAB 50,177–3,067,384 |
| Direct costs avoided (Third-Party Payer perspective) | BRL 17,980,716 | COP 1,465–21,631 million | PAB 117,004–3,167,029 |
| Productivity loss | BRL 35,265,257 | COP 272–544 million | PAB 191,123–298,149 |
| Total costs avoided (Societal perspective) | BRL 53,245,973 | COP 1,737–22,175 million | PAB 308,127–3,465,178 |
GP: General practitioner
*
Colombia and Panama: results are presented as a range using the 2 sets of values presented in Table 1.